Patents

Oral Treatment For Eczema and Psoriasis

US 8,535,696 B2; Lypanosys Pte Limited, Singapore, has been awarded a US patent covering a method of treatment of eczema in a mammal. It is comprised of administering an effective amount of an oral medicament consisting of cetyl myristate and/or an excipient and a diluent. 

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters